Crescent Capital BDC, Inc. CCAP 深 沪
等待开盘 06-08 09:30:00 美东时间
11.11
-0.400
-3.48%
华盛通- 最 高11.485
- 今 开11.44
- 成交量 20.52万股
- 最 低 11.08
- 昨 收 11.51
- 总市值 4.09亿
- 52周最高 14.745
- 市盈率 静 11.93
- 换手率 0.56%
- 52周最低 10.89
- 委 比 73.24%
- 总股本 3684.60万
- 历史最高 17.91
- 量 比 1.02
- 振 幅 3.52%
- 历史最低 -5.04
- 每 手 1
- 风险率 0.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多The High-Yield Stocks the Smart Money Is Buying Right Now
Smart credit team Ares Mgmt bought discounted BDCs aggressively in Q1 2026. They're not guessing but expressing conviction in 17 positions.
05-25 01:33
美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
Crescent Capital BDC Balances Fee Cuts And Credit Strain
Crescent Capital Bdc, Inc. (($CCAP)) has held its Q1 earnings call. Read on for...
05-15 08:22
Crescent Capital BDC Q1 Adj. EPS $0.42, Inline, Sales $37.912M Miss $39.459M Estimate
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is a 6.67 percent decrease over earnings of $0.45 per share from the same period last year.
05-14 05:43
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Crescent Capital BDC Elevates Executives to Board Leadership
The latest announcement is out from Crescent Capital BDC ( ($CCAP) ). On May 5,...
05-09 04:55
美股大行评级 | 美国银行、摩根士丹利、JB亨特运输服务、PNC金融服务、Cheniere Energy等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持FibroBiologics"买入"评级，目标价从4美元升至8美元；摩根士丹利：维持Ultragenyx药业"超配"评级，目标价从50美元升至67美元
04-17 11:27
Keefe, Bruyette & Woods Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $15
Keefe, Bruyette & Woods analyst Paul Johnson maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $15.5 to $15.
04-16 19:56
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
B. Riley Securities Initiates Coverage On Crescent Capital BDC with Neutral Rating, Announces Price Target of $13.5
B. Riley Securities analyst Sean-Paul Adams initiates coverage on Crescent Capital BDC (NASDAQ:CCAP) with a Neutral rating and announces Price Target of $13.5.
03-30 22:28
